nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—skin cancer	0.413	0.836	CbGaD
Acetylsalicylic acid—PTGS2—skin cancer	0.0807	0.164	CbGaD
Acetylsalicylic acid—ALB—Vismodegib—skin cancer	0.0416	0.138	CbGbCtD
Acetylsalicylic acid—SLC22A7—Fluorouracil—skin cancer	0.0408	0.135	CbGbCtD
Acetylsalicylic acid—ALB—Vemurafenib—skin cancer	0.0329	0.109	CbGbCtD
Acetylsalicylic acid—CYP2C8—Vismodegib—skin cancer	0.0321	0.107	CbGbCtD
Acetylsalicylic acid—SLC22A7—Docetaxel—skin cancer	0.0311	0.103	CbGbCtD
Acetylsalicylic acid—CYP2C19—Vismodegib—skin cancer	0.0269	0.0895	CbGbCtD
Acetylsalicylic acid—CYP2C9—Vismodegib—skin cancer	0.0224	0.0744	CbGbCtD
Acetylsalicylic acid—ABCB1—Vismodegib—skin cancer	0.0217	0.0722	CbGbCtD
Acetylsalicylic acid—ALB—Fluorouracil—skin cancer	0.0148	0.0491	CbGbCtD
Acetylsalicylic acid—ABCB1—Dactinomycin—skin cancer	0.0114	0.0379	CbGbCtD
Acetylsalicylic acid—CYP2C8—Fluorouracil—skin cancer	0.0114	0.0379	CbGbCtD
Acetylsalicylic acid—CYP2C9—Fluorouracil—skin cancer	0.00796	0.0264	CbGbCtD
Acetylsalicylic acid—ABCB1—Docetaxel—skin cancer	0.0059	0.0196	CbGbCtD
Acetylsalicylic acid—TP53—forelimb—skin cancer	0.00448	0.0572	CbGeAlD
Acetylsalicylic acid—TP53—arm—skin cancer	0.00385	0.0491	CbGeAlD
Acetylsalicylic acid—TP53—appendage—skin cancer	0.00345	0.0441	CbGeAlD
Acetylsalicylic acid—TP53—manus—skin cancer	0.00343	0.0437	CbGeAlD
Acetylsalicylic acid—TP53—manual digit—skin cancer	0.00335	0.0428	CbGeAlD
Acetylsalicylic acid—TP53—skin epidermis—skin cancer	0.00287	0.0367	CbGeAlD
Acetylsalicylic acid—NFKBIA—nerve—skin cancer	0.00241	0.0308	CbGeAlD
Acetylsalicylic acid—HSPA5—nerve—skin cancer	0.00236	0.0301	CbGeAlD
Acetylsalicylic acid—NFKBIA—Paclitaxel—Docetaxel—skin cancer	0.00228	1	CbGdCrCtD
Acetylsalicylic acid—TP53—endothelium—skin cancer	0.00209	0.0266	CbGeAlD
Acetylsalicylic acid—NFKBIA—endothelium—skin cancer	0.00205	0.0262	CbGeAlD
Acetylsalicylic acid—TP53—blood vessel—skin cancer	0.00192	0.0246	CbGeAlD
Acetylsalicylic acid—NFKBIA—blood vessel—skin cancer	0.00189	0.0242	CbGeAlD
Acetylsalicylic acid—TP53—nipple—skin cancer	0.00139	0.0178	CbGeAlD
Acetylsalicylic acid—TP53—neck—skin cancer	0.00138	0.0176	CbGeAlD
Acetylsalicylic acid—NFKBIA—nipple—skin cancer	0.00137	0.0175	CbGeAlD
Acetylsalicylic acid—NFKBIA—neck—skin cancer	0.00135	0.0173	CbGeAlD
Acetylsalicylic acid—HSPA5—nipple—skin cancer	0.00134	0.0171	CbGeAlD
Acetylsalicylic acid—HSPA5—neck—skin cancer	0.00133	0.0169	CbGeAlD
Acetylsalicylic acid—Clotting—Temozolomide—skin cancer	0.00131	0.027	CcSEcCtD
Acetylsalicylic acid—Hepatotoxicity—Vemurafenib—skin cancer	0.00118	0.0245	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—nipple—skin cancer	0.00114	0.0146	CbGeAlD
Acetylsalicylic acid—TP53—connective tissue—skin cancer	0.000986	0.0126	CbGeAlD
Acetylsalicylic acid—Hypokalaemia—Vismodegib—skin cancer	0.000978	0.0202	CcSEcCtD
Acetylsalicylic acid—NFKBIA—connective tissue—skin cancer	0.00097	0.0124	CbGeAlD
Acetylsalicylic acid—HSPA5—connective tissue—skin cancer	0.00095	0.0121	CbGeAlD
Acetylsalicylic acid—TP53—epithelium—skin cancer	0.000936	0.012	CbGeAlD
Acetylsalicylic acid—EDNRA—nipple—skin cancer	0.000928	0.0118	CbGeAlD
Acetylsalicylic acid—NFKBIA—epithelium—skin cancer	0.000921	0.0118	CbGeAlD
Acetylsalicylic acid—HSPA5—epithelium—skin cancer	0.000902	0.0115	CbGeAlD
Acetylsalicylic acid—TP53—skin of body—skin cancer	0.00089	0.0114	CbGeAlD
Acetylsalicylic acid—NFKBIA—skin of body—skin cancer	0.000876	0.0112	CbGeAlD
Acetylsalicylic acid—PTGS2—leg—skin cancer	0.000869	0.0111	CbGeAlD
Acetylsalicylic acid—HSPA5—skin of body—skin cancer	0.000858	0.011	CbGeAlD
Acetylsalicylic acid—IKBKB—nipple—skin cancer	0.000842	0.0108	CbGeAlD
Acetylsalicylic acid—Eruption—Dactinomycin—skin cancer	0.00084	0.0174	CcSEcCtD
Acetylsalicylic acid—Gout—Imiquimod—skin cancer	0.000835	0.0173	CcSEcCtD
Acetylsalicylic acid—Ulcer—Imiquimod—skin cancer	0.000824	0.017	CcSEcCtD
Acetylsalicylic acid—TP53—mammalian vulva—skin cancer	0.000812	0.0104	CbGeAlD
Acetylsalicylic acid—RPS6KA3—connective tissue—skin cancer	0.000809	0.0103	CbGeAlD
Acetylsalicylic acid—NFKBIA—mammalian vulva—skin cancer	0.000799	0.0102	CbGeAlD
Acetylsalicylic acid—HSPA5—mammalian vulva—skin cancer	0.000782	0.00999	CbGeAlD
Acetylsalicylic acid—PTGS2—hindlimb—skin cancer	0.000776	0.00991	CbGeAlD
Acetylsalicylic acid—TP53—lymphoid tissue—skin cancer	0.000721	0.00921	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymphoid tissue—skin cancer	0.000709	0.00906	CbGeAlD
Acetylsalicylic acid—TP53—female reproductive system—skin cancer	0.000695	0.00888	CbGeAlD
Acetylsalicylic acid—HSPA5—lymphoid tissue—skin cancer	0.000695	0.00887	CbGeAlD
Acetylsalicylic acid—NFKBIA—female reproductive system—skin cancer	0.000684	0.00874	CbGeAlD
Acetylsalicylic acid—HSPA5—female reproductive system—skin cancer	0.00067	0.00856	CbGeAlD
Acetylsalicylic acid—Hepatotoxicity—Dactinomycin—skin cancer	0.000669	0.0138	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—mammalian vulva—skin cancer	0.000666	0.00851	CbGeAlD
Acetylsalicylic acid—PTGS2—appendage—skin cancer	0.000666	0.0085	CbGeAlD
Acetylsalicylic acid—Coagulopathy—Dactinomycin—skin cancer	0.000664	0.0137	CcSEcCtD
Acetylsalicylic acid—Salicylate-sodium—PTGS2—skin cancer	0.000651	0.338	CrCbGaD
Acetylsalicylic acid—Heartburn—Fluorouracil—skin cancer	0.000626	0.0129	CcSEcCtD
Acetylsalicylic acid—Hepatotoxicity—Temozolomide—skin cancer	0.000605	0.0125	CcSEcCtD
Acetylsalicylic acid—Coagulopathy—Temozolomide—skin cancer	0.0006	0.0124	CcSEcCtD
Acetylsalicylic acid—IKBKB—connective tissue—skin cancer	0.000597	0.00763	CbGeAlD
Acetylsalicylic acid—RPS6KA3—lymphoid tissue—skin cancer	0.000592	0.00756	CbGeAlD
Acetylsalicylic acid—Purpura—Imiquimod—skin cancer	0.000587	0.0121	CcSEcCtD
Acetylsalicylic acid—Ulcer—Bleomycin—skin cancer	0.000586	0.0121	CcSEcCtD
Acetylsalicylic acid—TP53—head—skin cancer	0.000581	0.00742	CbGeAlD
Acetylsalicylic acid—NFKBIA—head—skin cancer	0.000572	0.0073	CbGeAlD
Acetylsalicylic acid—RPS6KA3—female reproductive system—skin cancer	0.000571	0.00729	CbGeAlD
Acetylsalicylic acid—HSPA5—head—skin cancer	0.00056	0.00715	CbGeAlD
Acetylsalicylic acid—PTGS2—skin epidermis—skin cancer	0.000554	0.00707	CbGeAlD
Acetylsalicylic acid—Arthralgia—Vismodegib—skin cancer	0.000551	0.0114	CcSEcCtD
Acetylsalicylic acid—Foetor hepaticus—Docetaxel—skin cancer	0.000548	0.0113	CcSEcCtD
Acetylsalicylic acid—Ulcer—Dactinomycin—skin cancer	0.000546	0.0113	CcSEcCtD
Acetylsalicylic acid—EDNRA—mammalian vulva—skin cancer	0.000542	0.00692	CbGeAlD
Acetylsalicylic acid—IKBKB—skin of body—skin cancer	0.000539	0.00689	CbGeAlD
Acetylsalicylic acid—Eruption—Docetaxel—skin cancer	0.000505	0.0104	CcSEcCtD
Acetylsalicylic acid—IKBKB—mammalian vulva—skin cancer	0.000492	0.00628	CbGeAlD
Acetylsalicylic acid—Hearing impaired—Temozolomide—skin cancer	0.000491	0.0101	CcSEcCtD
Acetylsalicylic acid—Influenza—Imiquimod—skin cancer	0.000489	0.0101	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—head—skin cancer	0.000477	0.00609	CbGeAlD
Acetylsalicylic acid—Respiratory failure—Temozolomide—skin cancer	0.000476	0.00983	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Vismodegib—skin cancer	0.000465	0.00961	CcSEcCtD
Acetylsalicylic acid—Liver disorder—Docetaxel—skin cancer	0.000456	0.00942	CcSEcCtD
Acetylsalicylic acid—Ulcer—Fluorouracil—skin cancer	0.000455	0.00941	CcSEcCtD
Acetylsalicylic acid—Heartburn—Docetaxel—skin cancer	0.000452	0.00933	CcSEcCtD
Acetylsalicylic acid—IKBKB—lymphoid tissue—skin cancer	0.000437	0.00558	CbGeAlD
Acetylsalicylic acid—IKBKB—female reproductive system—skin cancer	0.000421	0.00538	CbGeAlD
Acetylsalicylic acid—PTGS1—endothelium—skin cancer	0.00042	0.00537	CbGeAlD
Acetylsalicylic acid—TP53—lymph node—skin cancer	0.000407	0.00519	CbGeAlD
Acetylsalicylic acid—Hepatotoxicity—Docetaxel—skin cancer	0.000402	0.00832	CcSEcCtD
Acetylsalicylic acid—PTGS2—endothelium—skin cancer	0.000402	0.00513	CbGeAlD
Acetylsalicylic acid—NFKBIA—lymph node—skin cancer	0.0004	0.00511	CbGeAlD
Acetylsalicylic acid—Haemoglobin—Imiquimod—skin cancer	0.000394	0.00813	CcSEcCtD
Acetylsalicylic acid—Coma—Fluorouracil—skin cancer	0.000393	0.00813	CcSEcCtD
Acetylsalicylic acid—HSPA5—lymph node—skin cancer	0.000392	0.00501	CbGeAlD
Acetylsalicylic acid—Haemorrhage—Imiquimod—skin cancer	0.000392	0.00809	CcSEcCtD
Acetylsalicylic acid—PTGS1—blood vessel—skin cancer	0.000388	0.00495	CbGeAlD
Acetylsalicylic acid—Salsalate—PTGS2—skin cancer	0.00038	0.197	CrCbGaD
Acetylsalicylic acid—Deafness—Temozolomide—skin cancer	0.000379	0.00784	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Temozolomide—skin cancer	0.000379	0.00784	CcSEcCtD
Acetylsalicylic acid—Meclofenamic acid—PTGS2—skin cancer	0.000374	0.194	CrCbGaD
Acetylsalicylic acid—Pruritus—Vismodegib—skin cancer	0.000374	0.00772	CcSEcCtD
Acetylsalicylic acid—PTGS2—blood vessel—skin cancer	0.00037	0.00473	CbGeAlD
Acetylsalicylic acid—Tinnitus—Imiquimod—skin cancer	0.000365	0.00755	CcSEcCtD
Acetylsalicylic acid—Flushing—Imiquimod—skin cancer	0.000363	0.00751	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Vismodegib—skin cancer	0.000361	0.00747	CcSEcCtD
Acetylsalicylic acid—Thirst—Temozolomide—skin cancer	0.000356	0.00737	CcSEcCtD
Acetylsalicylic acid—IKBKB—head—skin cancer	0.000352	0.00449	CbGeAlD
Acetylsalicylic acid—Purpura—Temozolomide—skin cancer	0.000352	0.00727	CcSEcCtD
Acetylsalicylic acid—Chest discomfort—Docetaxel—skin cancer	0.000351	0.00726	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Vemurafenib—skin cancer	0.00034	0.00703	CcSEcCtD
Acetylsalicylic acid—Vomiting—Vismodegib—skin cancer	0.000336	0.00694	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—lymph node—skin cancer	0.000334	0.00426	CbGeAlD
Acetylsalicylic acid—Rash—Vismodegib—skin cancer	0.000333	0.00688	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Vismodegib—skin cancer	0.000333	0.00687	CcSEcCtD
Acetylsalicylic acid—Hearing impaired—Docetaxel—skin cancer	0.000326	0.00675	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Vemurafenib—skin cancer	0.000326	0.00674	CcSEcCtD
Acetylsalicylic acid—Respiratory failure—Docetaxel—skin cancer	0.000316	0.00654	CcSEcCtD
Acetylsalicylic acid—Nausea—Vismodegib—skin cancer	0.000314	0.00648	CcSEcCtD
Acetylsalicylic acid—Agitation—Imiquimod—skin cancer	0.000313	0.00647	CcSEcCtD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.000313	0.00646	CcSEcCtD
Acetylsalicylic acid—Angioedema—Imiquimod—skin cancer	0.000311	0.00644	CcSEcCtD
Acetylsalicylic acid—Hepatocellular injury—Docetaxel—skin cancer	0.000311	0.00642	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Temozolomide—skin cancer	0.000309	0.00638	CcSEcCtD
Acetylsalicylic acid—Syncope—Imiquimod—skin cancer	0.000306	0.00632	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Imiquimod—skin cancer	0.0003	0.00619	CcSEcCtD
Acetylsalicylic acid—Convulsion—Imiquimod—skin cancer	0.000295	0.0061	CcSEcCtD
Acetylsalicylic acid—Hypertension—Imiquimod—skin cancer	0.000294	0.00608	CcSEcCtD
Acetylsalicylic acid—Mefenamic acid—PTGS2—skin cancer	0.000291	0.151	CrCbGaD
Acetylsalicylic acid—Arthralgia—Imiquimod—skin cancer	0.00029	0.006	CcSEcCtD
Acetylsalicylic acid—Chest pain—Imiquimod—skin cancer	0.00029	0.006	CcSEcCtD
Acetylsalicylic acid—PTGS1—nipple—skin cancer	0.00028	0.00358	CbGeAlD
Acetylsalicylic acid—Haemoglobin—Bleomycin—skin cancer	0.00028	0.00578	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Bleomycin—skin cancer	0.000278	0.00575	CcSEcCtD
Acetylsalicylic acid—Lightheadedness—Docetaxel—skin cancer	0.000278	0.00575	CcSEcCtD
Acetylsalicylic acid—Shock—Imiquimod—skin cancer	0.000274	0.00566	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Imiquimod—skin cancer	0.000272	0.00561	CcSEcCtD
Acetylsalicylic acid—EDNRA—lymph node—skin cancer	0.000271	0.00347	CbGeAlD
Acetylsalicylic acid—Hyperhidrosis—Imiquimod—skin cancer	0.000269	0.00556	CcSEcCtD
Acetylsalicylic acid—Flushing—Bleomycin—skin cancer	0.000258	0.00534	CcSEcCtD
Acetylsalicylic acid—Deafness—Docetaxel—skin cancer	0.000252	0.00521	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Imiquimod—skin cancer	0.000248	0.00513	CcSEcCtD
Acetylsalicylic acid—Somnolence—Imiquimod—skin cancer	0.000247	0.00511	CcSEcCtD
Acetylsalicylic acid—IKBKB—lymph node—skin cancer	0.000246	0.00315	CbGeAlD
Acetylsalicylic acid—Dyspepsia—Imiquimod—skin cancer	0.000245	0.00506	CcSEcCtD
Acetylsalicylic acid—Flushing—Dactinomycin—skin cancer	0.000241	0.00498	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Vemurafenib—skin cancer	0.00024	0.00497	CcSEcCtD
Acetylsalicylic acid—Renal impairment—Docetaxel—skin cancer	0.000237	0.0049	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Temozolomide—skin cancer	0.000236	0.00487	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Temozolomide—skin cancer	0.000235	0.00485	CcSEcCtD
Acetylsalicylic acid—Salicylic acid—PTGS2—skin cancer	0.000233	0.121	CrCbGaD
Acetylsalicylic acid—Pruritus—Vemurafenib—skin cancer	0.000231	0.00477	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Imiquimod—skin cancer	0.000229	0.00474	CcSEcCtD
Acetylsalicylic acid—ABCB1—blood vessel—skin cancer	0.000229	0.00293	CbGeAlD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.000226	0.00466	CcSEcCtD
Acetylsalicylic acid—Anaemia—Bleomycin—skin cancer	0.000224	0.00463	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Vemurafenib—skin cancer	0.000223	0.00461	CcSEcCtD
Acetylsalicylic acid—Urticaria—Imiquimod—skin cancer	0.000221	0.00457	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Temozolomide—skin cancer	0.000219	0.00452	CcSEcCtD
Acetylsalicylic acid—Flushing—Temozolomide—skin cancer	0.000218	0.0045	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Fluorouracil—skin cancer	0.000217	0.00449	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Bleomycin—skin cancer	0.000217	0.00448	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Fluorouracil—skin cancer	0.000216	0.00447	CcSEcCtD
Acetylsalicylic acid—Dizziness—Vemurafenib—skin cancer	0.000216	0.00446	CcSEcCtD
Acetylsalicylic acid—Anaemia—Dactinomycin—skin cancer	0.000209	0.00431	CcSEcCtD
Acetylsalicylic acid—Vomiting—Vemurafenib—skin cancer	0.000207	0.00429	CcSEcCtD
Acetylsalicylic acid—Chest pain—Bleomycin—skin cancer	0.000206	0.00426	CcSEcCtD
Acetylsalicylic acid—Rash—Vemurafenib—skin cancer	0.000206	0.00425	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Vemurafenib—skin cancer	0.000205	0.00425	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Imiquimod—skin cancer	0.000205	0.00424	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Dactinomycin—skin cancer	0.000202	0.00418	CcSEcCtD
Acetylsalicylic acid—Confusional state—Bleomycin—skin cancer	0.000199	0.00412	CcSEcCtD
Acetylsalicylic acid—PTGS1—connective tissue—skin cancer	0.000199	0.00254	CbGeAlD
Acetylsalicylic acid—Anaphylactic shock—Bleomycin—skin cancer	0.000198	0.00408	CcSEcCtD
Acetylsalicylic acid—Pruritus—Imiquimod—skin cancer	0.000197	0.00407	CcSEcCtD
Acetylsalicylic acid—Nausea—Vemurafenib—skin cancer	0.000194	0.004	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Bleomycin—skin cancer	0.000194	0.004	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Imiquimod—skin cancer	0.00019	0.00393	CcSEcCtD
Acetylsalicylic acid—PTGS2—connective tissue—skin cancer	0.00019	0.00243	CbGeAlD
Acetylsalicylic acid—Anaemia—Temozolomide—skin cancer	0.000189	0.0039	CcSEcCtD
Acetylsalicylic acid—PTGS1—epithelium—skin cancer	0.000189	0.00241	CbGeAlD
Acetylsalicylic acid—Agitation—Temozolomide—skin cancer	0.000188	0.00388	CcSEcCtD
Acetylsalicylic acid—Angioedema—Temozolomide—skin cancer	0.000187	0.00386	CcSEcCtD
Acetylsalicylic acid—Dizziness—Imiquimod—skin cancer	0.000184	0.0038	CcSEcCtD
Acetylsalicylic acid—Vertigo—Temozolomide—skin cancer	0.000184	0.00379	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Temozolomide—skin cancer	0.000183	0.00378	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Dactinomycin—skin cancer	0.00018	0.00373	CcSEcCtD
Acetylsalicylic acid—PTGS2—epithelium—skin cancer	0.00018	0.0023	CbGeAlD
Acetylsalicylic acid—PTGS1—skin of body—skin cancer	0.000179	0.00229	CbGeAlD
Acetylsalicylic acid—Convulsion—Temozolomide—skin cancer	0.000177	0.00366	CcSEcCtD
Acetylsalicylic acid—Vomiting—Imiquimod—skin cancer	0.000177	0.00366	CcSEcCtD
Acetylsalicylic acid—Hypertension—Temozolomide—skin cancer	0.000176	0.00364	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Bleomycin—skin cancer	0.000176	0.00364	CcSEcCtD
Acetylsalicylic acid—Rash—Imiquimod—skin cancer	0.000175	0.00363	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Imiquimod—skin cancer	0.000175	0.00362	CcSEcCtD
Acetylsalicylic acid—Anaemia—Fluorouracil—skin cancer	0.000174	0.0036	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Temozolomide—skin cancer	0.000174	0.00359	CcSEcCtD
Acetylsalicylic acid—CYP2C8—female reproductive system—skin cancer	0.000173	0.00221	CbGeAlD
Acetylsalicylic acid—PTGS2—skin of body—skin cancer	0.000172	0.00219	CbGeAlD
Acetylsalicylic acid—Leukopenia—Fluorouracil—skin cancer	0.000168	0.00348	CcSEcCtD
Acetylsalicylic acid—Confusional state—Temozolomide—skin cancer	0.000168	0.00347	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Temozolomide—skin cancer	0.000167	0.00345	CcSEcCtD
Acetylsalicylic acid—Nausea—Imiquimod—skin cancer	0.000165	0.00342	CcSEcCtD
Acetylsalicylic acid—PTGS1—mammalian vulva—skin cancer	0.000164	0.00209	CbGeAlD
Acetylsalicylic acid—Thrombocytopenia—Temozolomide—skin cancer	0.000163	0.00337	CcSEcCtD
Acetylsalicylic acid—Convulsion—Fluorouracil—skin cancer	0.000163	0.00337	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Bleomycin—skin cancer	0.000163	0.00337	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Temozolomide—skin cancer	0.000161	0.00333	CcSEcCtD
Acetylsalicylic acid—Chest pain—Fluorouracil—skin cancer	0.00016	0.00331	CcSEcCtD
Acetylsalicylic acid—Urticaria—Bleomycin—skin cancer	0.000157	0.00324	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Docetaxel—skin cancer	0.000157	0.00324	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Docetaxel—skin cancer	0.000156	0.00323	CcSEcCtD
Acetylsalicylic acid—Confusional state—Fluorouracil—skin cancer	0.000155	0.0032	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Fluorouracil—skin cancer	0.000154	0.00317	CcSEcCtD
Acetylsalicylic acid—CYP2C9—female reproductive system—skin cancer	0.000154	0.00196	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Dactinomycin—skin cancer	0.000152	0.00314	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Fluorouracil—skin cancer	0.00015	0.00311	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Fluorouracil—skin cancer	0.00015	0.0031	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Temozolomide—skin cancer	0.000149	0.00307	CcSEcCtD
Acetylsalicylic acid—Somnolence—Temozolomide—skin cancer	0.000148	0.00306	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Temozolomide—skin cancer	0.000147	0.00303	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Bleomycin—skin cancer	0.000146	0.00301	CcSEcCtD
Acetylsalicylic acid—Flushing—Docetaxel—skin cancer	0.000145	0.00299	CcSEcCtD
Acetylsalicylic acid—ALB—lymph node—skin cancer	0.000144	0.00184	CbGeAlD
Acetylsalicylic acid—PTGS1—female reproductive system—skin cancer	0.00014	0.00179	CbGeAlD
Acetylsalicylic acid—Pruritus—Bleomycin—skin cancer	0.00014	0.00289	CcSEcCtD
Acetylsalicylic acid—PTGS2—lymphoid tissue—skin cancer	0.000139	0.00177	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Temozolomide—skin cancer	0.000137	0.00284	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Fluorouracil—skin cancer	0.000137	0.00283	CcSEcCtD
Acetylsalicylic acid—Somnolence—Fluorouracil—skin cancer	0.000137	0.00282	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Dactinomycin—skin cancer	0.000136	0.00281	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Fluorouracil—skin cancer	0.000135	0.00279	CcSEcCtD
Acetylsalicylic acid—PTGS2—female reproductive system—skin cancer	0.000134	0.00171	CbGeAlD
Acetylsalicylic acid—Urticaria—Temozolomide—skin cancer	0.000132	0.00274	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Fluorouracil—skin cancer	0.000127	0.00262	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Dactinomycin—skin cancer	0.000126	0.00261	CcSEcCtD
Acetylsalicylic acid—Vomiting—Bleomycin—skin cancer	0.000126	0.0026	CcSEcCtD
Acetylsalicylic acid—Anaemia—Docetaxel—skin cancer	0.000126	0.00259	CcSEcCtD
Acetylsalicylic acid—Rash—Bleomycin—skin cancer	0.000125	0.00258	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Bleomycin—skin cancer	0.000124	0.00257	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Temozolomide—skin cancer	0.000123	0.00254	CcSEcCtD
Acetylsalicylic acid—Urticaria—Fluorouracil—skin cancer	0.000122	0.00252	CcSEcCtD
Acetylsalicylic acid—Syncope—Docetaxel—skin cancer	0.000122	0.00252	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Docetaxel—skin cancer	0.000122	0.00251	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Docetaxel—skin cancer	0.000119	0.00247	CcSEcCtD
Acetylsalicylic acid—Pruritus—Temozolomide—skin cancer	0.000118	0.00244	CcSEcCtD
Acetylsalicylic acid—Convulsion—Docetaxel—skin cancer	0.000118	0.00243	CcSEcCtD
Acetylsalicylic acid—Nausea—Bleomycin—skin cancer	0.000117	0.00243	CcSEcCtD
Acetylsalicylic acid—Hypertension—Docetaxel—skin cancer	0.000117	0.00242	CcSEcCtD
Acetylsalicylic acid—Vomiting—Dactinomycin—skin cancer	0.000117	0.00242	CcSEcCtD
Acetylsalicylic acid—PTGS1—head—skin cancer	0.000117	0.0015	CbGeAlD
Acetylsalicylic acid—Rash—Dactinomycin—skin cancer	0.000116	0.0024	CcSEcCtD
Acetylsalicylic acid—Chest pain—Docetaxel—skin cancer	0.000116	0.00239	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Docetaxel—skin cancer	0.000116	0.00239	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Temozolomide—skin cancer	0.000114	0.00236	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Fluorouracil—skin cancer	0.000113	0.00234	CcSEcCtD
Acetylsalicylic acid—PTGS2—head—skin cancer	0.000112	0.00143	CbGeAlD
Acetylsalicylic acid—Confusional state—Docetaxel—skin cancer	0.000112	0.00231	CcSEcCtD
Acetylsalicylic acid—ABCB1—epithelium—skin cancer	0.000112	0.00142	CbGeAlD
Acetylsalicylic acid—Anaphylactic shock—Docetaxel—skin cancer	0.000111	0.00229	CcSEcCtD
Acetylsalicylic acid—Dizziness—Temozolomide—skin cancer	0.00011	0.00228	CcSEcCtD
Acetylsalicylic acid—Nausea—Dactinomycin—skin cancer	0.000109	0.00226	CcSEcCtD
Acetylsalicylic acid—Shock—Docetaxel—skin cancer	0.000109	0.00225	CcSEcCtD
Acetylsalicylic acid—Pruritus—Fluorouracil—skin cancer	0.000109	0.00225	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Docetaxel—skin cancer	0.000109	0.00224	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Docetaxel—skin cancer	0.000108	0.00224	CcSEcCtD
Acetylsalicylic acid—Vomiting—Temozolomide—skin cancer	0.000106	0.00219	CcSEcCtD
Acetylsalicylic acid—Rash—Temozolomide—skin cancer	0.000105	0.00217	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Fluorouracil—skin cancer	0.000105	0.00217	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Temozolomide—skin cancer	0.000105	0.00217	CcSEcCtD
Acetylsalicylic acid—Dizziness—Fluorouracil—skin cancer	0.000102	0.0021	CcSEcCtD
Acetylsalicylic acid—Nausea—Temozolomide—skin cancer	9.9e-05	0.00205	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Docetaxel—skin cancer	9.88e-05	0.00204	CcSEcCtD
Acetylsalicylic acid—Somnolence—Docetaxel—skin cancer	9.86e-05	0.00204	CcSEcCtD
Acetylsalicylic acid—Vomiting—Fluorouracil—skin cancer	9.77e-05	0.00202	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Docetaxel—skin cancer	9.76e-05	0.00202	CcSEcCtD
Acetylsalicylic acid—Rash—Fluorouracil—skin cancer	9.68e-05	0.002	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Fluorouracil—skin cancer	9.68e-05	0.002	CcSEcCtD
Acetylsalicylic acid—ABCB1—mammalian vulva—skin cancer	9.68e-05	0.00124	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Docetaxel—skin cancer	9.14e-05	0.00189	CcSEcCtD
Acetylsalicylic acid—Nausea—Fluorouracil—skin cancer	9.12e-05	0.00189	CcSEcCtD
Acetylsalicylic acid—ABCB1—lymphoid tissue—skin cancer	8.59e-05	0.0011	CbGeAlD
Acetylsalicylic acid—ABCB1—female reproductive system—skin cancer	8.29e-05	0.00106	CbGeAlD
Acetylsalicylic acid—PTGS1—lymph node—skin cancer	8.2e-05	0.00105	CbGeAlD
Acetylsalicylic acid—Hypersensitivity—Docetaxel—skin cancer	8.17e-05	0.00169	CcSEcCtD
Acetylsalicylic acid—Pruritus—Docetaxel—skin cancer	7.84e-05	0.00162	CcSEcCtD
Acetylsalicylic acid—PTGS2—lymph node—skin cancer	7.84e-05	0.001	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Docetaxel—skin cancer	7.59e-05	0.00157	CcSEcCtD
Acetylsalicylic acid—Dizziness—Docetaxel—skin cancer	7.33e-05	0.00152	CcSEcCtD
Acetylsalicylic acid—Vomiting—Docetaxel—skin cancer	7.05e-05	0.00146	CcSEcCtD
Acetylsalicylic acid—Rash—Docetaxel—skin cancer	6.99e-05	0.00144	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Docetaxel—skin cancer	6.98e-05	0.00144	CcSEcCtD
Acetylsalicylic acid—ABCB1—head—skin cancer	6.92e-05	0.000884	CbGeAlD
Acetylsalicylic acid—Nausea—Docetaxel—skin cancer	6.59e-05	0.00136	CcSEcCtD
Acetylsalicylic acid—ABCB1—lymph node—skin cancer	4.85e-05	0.000619	CbGeAlD
Acetylsalicylic acid—IKBKB—Innate Immune System—FOXO4—skin cancer	3.09e-05	0.000414	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—skin cancer	3.08e-05	0.000412	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—PTCH1—skin cancer	3.05e-05	0.000408	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—SMO—skin cancer	3.05e-05	0.000408	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.03e-05	0.000406	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—PTCH1—skin cancer	3.01e-05	0.000403	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—SMO—skin cancer	3.01e-05	0.000403	CbGpPWpGaD
Acetylsalicylic acid—TP53—Cellular responses to stress—IL6—skin cancer	2.99e-05	0.000401	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—FOXO4—skin cancer	2.97e-05	0.000398	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling by NGF—HRAS—skin cancer	2.97e-05	0.000397	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—PTGER4—skin cancer	2.97e-05	0.000397	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Cellular responses to stress—TP53—skin cancer	2.96e-05	0.000396	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MyD88-independent cascade—IL6—skin cancer	2.95e-05	0.000395	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—PTGER4—skin cancer	2.93e-05	0.000393	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	2.93e-05	0.000392	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.92e-05	0.000392	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll-like Receptor Signaling Pathway—IL6—skin cancer	2.88e-05	0.000386	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by Interleukins—HRAS—skin cancer	2.88e-05	0.000385	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—SHH—skin cancer	2.87e-05	0.000385	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—SHH—skin cancer	2.87e-05	0.000385	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—BRAF—skin cancer	2.87e-05	0.000384	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—RASA1—skin cancer	2.86e-05	0.000382	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—RASA1—skin cancer	2.86e-05	0.000382	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling by NGF—IL6—skin cancer	2.84e-05	0.00038	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Adaptive Immune System—HRAS—skin cancer	2.83e-05	0.000379	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Axon guidance—KRAS—skin cancer	2.82e-05	0.000378	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—ERCC2—skin cancer	2.79e-05	0.000374	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTCH2—skin cancer	2.77e-05	0.000372	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—NRAS—skin cancer	2.77e-05	0.000371	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—NRAS—skin cancer	2.76e-05	0.00037	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by Interleukins—IL6—skin cancer	2.75e-05	0.000369	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—SMO—skin cancer	2.72e-05	0.000365	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PTCH1—skin cancer	2.72e-05	0.000365	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PTCH1—skin cancer	2.72e-05	0.000365	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—SMO—skin cancer	2.72e-05	0.000365	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Cellular responses to stress—IL6—skin cancer	2.71e-05	0.000363	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Neuronal System—HRAS—skin cancer	2.71e-05	0.000362	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—C-MYB transcription factor network—KRAS—skin cancer	2.7e-05	0.000362	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Selenium Micronutrient Network—IL6—skin cancer	2.67e-05	0.000357	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Activated TLR4 signalling—IL6—skin cancer	2.65e-05	0.000355	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by NGF—HRAS—skin cancer	2.65e-05	0.000355	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PTGER4—skin cancer	2.65e-05	0.000355	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PTGER4—skin cancer	2.65e-05	0.000355	CbGpPWpGaD
Acetylsalicylic acid—ALB—Vitamin B12 Metabolism—IL6—skin cancer	2.65e-05	0.000355	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—NRAS—skin cancer	2.65e-05	0.000355	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—FOXO4—skin cancer	2.62e-05	0.000351	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—FOXO4—skin cancer	2.59e-05	0.000347	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PLIN2—skin cancer	2.57e-05	0.000344	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—NRAS—skin cancer	2.54e-05	0.00034	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by NGF—IL6—skin cancer	2.54e-05	0.00034	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—skin cancer	2.5e-05	0.000334	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—BRAF—skin cancer	2.47e-05	0.000331	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—NRAS—skin cancer	2.45e-05	0.000328	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Axon guidance—HRAS—skin cancer	2.4e-05	0.000322	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—skin cancer	2.39e-05	0.00032	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—KRAS—skin cancer	2.38e-05	0.000318	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—TP53—skin cancer	2.36e-05	0.000316	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—NRAS—skin cancer	2.35e-05	0.000314	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—FOXO4—skin cancer	2.34e-05	0.000314	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—FOXO4—skin cancer	2.34e-05	0.000314	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—NRAS—skin cancer	2.34e-05	0.000314	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—NRAS—skin cancer	2.31e-05	0.00031	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Axon guidance—IL6—skin cancer	2.3e-05	0.000308	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—C-MYB transcription factor network—HRAS—skin cancer	2.3e-05	0.000308	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—BDNF signaling pathway—HRAS—skin cancer	2.28e-05	0.000306	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—skin cancer	2.28e-05	0.000305	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—skin cancer	2.25e-05	0.000301	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Toll-Like Receptors Cascades—IL6—skin cancer	2.22e-05	0.000298	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—NRAS—skin cancer	2.22e-05	0.000298	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TERT—skin cancer	2.19e-05	0.000293	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—KRAS—skin cancer	2.19e-05	0.000293	CbGpPWpGaD
Acetylsalicylic acid—ALB—Folate Metabolism—IL6—skin cancer	2.16e-05	0.000289	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Selenium Micronutrient Network—IL6—skin cancer	2.12e-05	0.000284	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—TP53—skin cancer	2.11e-05	0.000283	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—KRAS—skin cancer	2.11e-05	0.000282	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—GLI2—skin cancer	2.1e-05	0.000282	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Insulin Signaling—HRAS—skin cancer	2.1e-05	0.000281	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	2.07e-05	0.000278	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—CSPG4—skin cancer	2.07e-05	0.000277	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—NRAS—skin cancer	2.07e-05	0.000277	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PLIN2—skin cancer	2.04e-05	0.000273	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—skin cancer	2.03e-05	0.000272	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—KRAS—skin cancer	2.02e-05	0.00027	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—KRAS—skin cancer	2.02e-05	0.00027	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MC1R—skin cancer	2.01e-05	0.000269	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—PTGS2—skin cancer	2e-05	0.000267	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—KRAS—skin cancer	1.99e-05	0.000267	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—GLI1—skin cancer	1.98e-05	0.000265	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CSPG4—skin cancer	1.96e-05	0.000263	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	1.94e-05	0.000259	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—KRAS—skin cancer	1.91e-05	0.000256	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SUFU—skin cancer	1.87e-05	0.000251	CbGpPWpGaD
Acetylsalicylic acid—TP53—Hemostasis—HRAS—skin cancer	1.86e-05	0.000249	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	1.85e-05	0.000248	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—NRAS—skin cancer	1.83e-05	0.000246	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TP53—skin cancer	1.83e-05	0.000245	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—NRAS—skin cancer	1.8e-05	0.000242	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—FOXO4—skin cancer	1.8e-05	0.000241	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—B Cell Activation—HRAS—skin cancer	1.79e-05	0.00024	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—KRAS—skin cancer	1.78e-05	0.000238	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TERT—skin cancer	1.75e-05	0.000234	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—BRAF—skin cancer	1.73e-05	0.000232	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—TERT—skin cancer	1.73e-05	0.000232	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—HRAS—skin cancer	1.72e-05	0.00023	CbGpPWpGaD
Acetylsalicylic acid—ALB—Selenium Micronutrient Network—IL6—skin cancer	1.71e-05	0.000229	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—HRAS—skin cancer	1.71e-05	0.000229	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—HRAS—skin cancer	1.69e-05	0.000227	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—IL6—skin cancer	1.67e-05	0.000224	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—PTGS2—skin cancer	1.67e-05	0.000224	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PLIN2—skin cancer	1.66e-05	0.000222	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PLIN2—skin cancer	1.65e-05	0.000221	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—IL6—skin cancer	1.64e-05	0.00022	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CSPG4—skin cancer	1.64e-05	0.00022	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—IL6—skin cancer	1.64e-05	0.00022	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—HRAS—skin cancer	1.63e-05	0.000218	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—IL6—skin cancer	1.62e-05	0.000217	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—KRAS—skin cancer	1.58e-05	0.000211	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TERT—skin cancer	1.56e-05	0.00021	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TERT—skin cancer	1.56e-05	0.00021	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—NRAS—skin cancer	1.55e-05	0.000208	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—KRAS—skin cancer	1.55e-05	0.000208	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—HRAS—skin cancer	1.51e-05	0.000203	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	1.48e-05	0.000199	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PLIN2—skin cancer	1.48e-05	0.000198	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—IL6—skin cancer	1.45e-05	0.000194	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PLIN2—skin cancer	1.44e-05	0.000193	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SHH—skin cancer	1.43e-05	0.000191	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—RASA1—skin cancer	1.42e-05	0.00019	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ENO2—skin cancer	1.41e-05	0.000188	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.4e-05	0.000188	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—BRAF—skin cancer	1.39e-05	0.000186	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—BRAF—skin cancer	1.37e-05	0.000184	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTCH1—skin cancer	1.36e-05	0.000181	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SMO—skin cancer	1.36e-05	0.000181	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PLIN2—skin cancer	1.35e-05	0.000181	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—NRAS—skin cancer	1.35e-05	0.00018	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—HRAS—skin cancer	1.34e-05	0.00018	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—KRAS—skin cancer	1.34e-05	0.000179	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CSPG4—skin cancer	1.34e-05	0.000179	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ENO2—skin cancer	1.33e-05	0.000179	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SHH—skin cancer	1.33e-05	0.000179	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CSPG4—skin cancer	1.33e-05	0.000178	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—HRAS—skin cancer	1.32e-05	0.000177	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTGER4—skin cancer	1.32e-05	0.000177	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—NRAS—skin cancer	1.32e-05	0.000177	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—NRAS—skin cancer	1.32e-05	0.000177	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL6—skin cancer	1.28e-05	0.000172	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—IL6—skin cancer	1.26e-05	0.000169	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.24e-05	0.000167	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—BRAF—skin cancer	1.24e-05	0.000166	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—BRAF—skin cancer	1.24e-05	0.000166	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—NRAS—skin cancer	1.2e-05	0.000161	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CSPG4—skin cancer	1.19e-05	0.00016	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—FOXO4—skin cancer	1.17e-05	0.000156	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CSPG4—skin cancer	1.16e-05	0.000156	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—KRAS—skin cancer	1.16e-05	0.000155	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—HRAS—skin cancer	1.14e-05	0.000152	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—KRAS—skin cancer	1.13e-05	0.000152	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—KRAS—skin cancer	1.13e-05	0.000152	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ENO2—skin cancer	1.12e-05	0.00015	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.1e-05	0.000147	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—NRAS—skin cancer	1.09e-05	0.000146	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—IL6—skin cancer	1.09e-05	0.000146	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—CSPG4—skin cancer	1.09e-05	0.000146	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—FOXO4—skin cancer	1.09e-05	0.000146	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—KRAS—skin cancer	1.04e-05	0.000139	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—NRAS—skin cancer	1.03e-05	0.000138	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	9.93e-06	0.000133	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—NRAS—skin cancer	9.88e-06	0.000132	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—HRAS—skin cancer	9.86e-06	0.000132	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—HRAS—skin cancer	9.65e-06	0.000129	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—HRAS—skin cancer	9.65e-06	0.000129	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL6—skin cancer	9.44e-06	0.000126	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—KRAS—skin cancer	9.37e-06	0.000125	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—IL6—skin cancer	9.23e-06	0.000124	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—IL6—skin cancer	9.23e-06	0.000124	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ENO2—skin cancer	9.09e-06	0.000122	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ENO2—skin cancer	9.03e-06	0.000121	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—KRAS—skin cancer	8.85e-06	0.000119	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	8.82e-06	0.000118	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—HRAS—skin cancer	8.81e-06	0.000118	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—NRAS—skin cancer	8.71e-06	0.000117	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—NRAS—skin cancer	8.61e-06	0.000115	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—KRAS—skin cancer	8.5e-06	0.000114	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL6—skin cancer	8.44e-06	0.000113	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TP53—skin cancer	8.32e-06	0.000111	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ERCC2—skin cancer	8.17e-06	0.000109	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ENO2—skin cancer	8.11e-06	0.000109	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—HRAS—skin cancer	7.96e-06	0.000107	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ENO2—skin cancer	7.92e-06	0.000106	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NRAS—skin cancer	7.79e-06	0.000104	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NRAS—skin cancer	7.79e-06	0.000104	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TERT—skin cancer	7.78e-06	0.000104	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ERCC2—skin cancer	7.75e-06	0.000104	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL6—skin cancer	7.62e-06	0.000102	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—HRAS—skin cancer	7.53e-06	0.000101	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—KRAS—skin cancer	7.5e-06	0.0001	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—KRAS—skin cancer	7.41e-06	9.93e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ENO2—skin cancer	7.4e-06	9.9e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—TERT—skin cancer	7.26e-06	9.72e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—HRAS—skin cancer	7.23e-06	9.68e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—IL6—skin cancer	7.2e-06	9.64e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	7.11e-06	9.52e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	7.07e-06	9.46e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—KRAS—skin cancer	6.7e-06	8.98e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—KRAS—skin cancer	6.7e-06	8.98e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—skin cancer	6.66e-06	8.93e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ERCC2—skin cancer	6.49e-06	8.69e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HRAS—skin cancer	6.37e-06	8.54e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.34e-06	8.49e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HRAS—skin cancer	6.3e-06	8.44e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—BRAF—skin cancer	6.16e-06	8.25e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL6—skin cancer	6.1e-06	8.17e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—NRAS—skin cancer	6.04e-06	8.09e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL6—skin cancer	6.03e-06	8.08e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—NRAS—skin cancer	5.99e-06	8.02e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—skin cancer	5.96e-06	7.98e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—skin cancer	5.96e-06	7.98e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.78e-06	7.74e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—BRAF—skin cancer	5.75e-06	7.7e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HRAS—skin cancer	5.7e-06	7.63e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HRAS—skin cancer	5.7e-06	7.63e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL6—skin cancer	5.45e-06	7.3e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL6—skin cancer	5.45e-06	7.3e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ERCC2—skin cancer	5.28e-06	7.07e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ERCC2—skin cancer	5.25e-06	7.03e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—KRAS—skin cancer	5.2e-06	6.96e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—KRAS—skin cancer	5.16e-06	6.91e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PTGS2—skin cancer	4.9e-06	6.56e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ERCC2—skin cancer	4.71e-06	6.31e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—skin cancer	4.62e-06	6.19e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ERCC2—skin cancer	4.6e-06	6.16e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—HRAS—skin cancer	4.42e-06	5.92e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—HRAS—skin cancer	4.38e-06	5.87e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ERCC2—skin cancer	4.3e-06	5.75e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL6—skin cancer	4.19e-06	5.62e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NRAS—skin cancer	3.87e-06	5.19e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—NRAS—skin cancer	3.61e-06	4.84e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—KRAS—skin cancer	3.33e-06	4.46e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PTGS2—skin cancer	3.16e-06	4.24e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PTGS2—skin cancer	3.15e-06	4.21e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—KRAS—skin cancer	3.11e-06	4.16e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—skin cancer	2.96e-06	3.97e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HRAS—skin cancer	2.83e-06	3.79e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PTGS2—skin cancer	2.82e-06	3.78e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PTGS2—skin cancer	2.76e-06	3.69e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL6—skin cancer	2.71e-06	3.63e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HRAS—skin cancer	2.64e-06	3.54e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PTGS2—skin cancer	2.58e-06	3.45e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IL6—skin cancer	2.53e-06	3.39e-05	CbGpPWpGaD
